Related Experiment Videos
[Allergic reactions during streptokinase therapy].
1Medizinische Klinik II, Eberhard-Karls Universitaet, Tubingen, Vest-Tyskland.
Summary
This review covers immune responses to streptokinase, detailing antibody (IgG, IgM, IgE) and T cell (CD4, CD8) involvement. Understanding these reactions is crucial for managing allergic side effects during streptokinase therapy.
Area of Science:
- Immunology
- Allergology
Context:
- Streptokinase is a thrombolytic agent used in treating cardiovascular events.
- Immunological reactions can complicate streptokinase therapy.
- Understanding the immune response is key to patient safety.
Purpose:
- To review the immunological reactions to streptokinase.
- To detail the humoral and cellular immune responses.
- To highlight the risks of allergic reactions associated with streptokinase therapy.
Summary:
- Humoral immunity involves IgG, IgM, and IgE antibodies against streptokinase.
- Cellular immunity includes CD4 and CD8 T cell responses.
- Therapeutic use of streptokinase is associated with allergic reactions like urticaria, shock, and serum sickness.
Impact:
- Provides a comprehensive overview of streptokinase immunology.
- Informs clinical practice regarding patient monitoring and risk management.
- Contributes to the understanding of drug-induced hypersensitivity.